Collier Collective, LLC

Collier Collective, LLC filed a Q1 report for Avac (AIDS Vaccine and Advocacy Coalition) on May 26, 2026.

Lobbying for Avac (AIDS Vaccine and Advocacy Coalition) · AVAC works to ensure ethical development of and access to effective HIV prevention options

As filed: COLLIER COLLECTIVE, LLC for AVAC (AIDS VACCINE AND ADVOCACY COALITION).

All filings by Collier Collective, LLC · Everything Avac (AIDS Vaccine and Advocacy Coalition) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted May 26, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New York

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Budget/Appropriations

Advocated for Congress to ensure expenditure of FY25 appropriations and robustly appropriate funding for FY26 and FY27 for HIV/AIDS treatment and prevention programs in the Health Resources and Services Administration (HRSA) and the Center for Disease Control and Prevention(CDC) at the Dept. of Health & Human Services, including the Ryan White HIV/AIDS Program (HRSA), the Ending the HIV Epidemic program (HRSA & CDC), a national pre-exposure prophylaxis (PrEP) initiative (CDC), and HIV research programs at NIH that would be appropriated through the Labor, Health & Human Services, Education, and Related Agencies appropriations bill.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.